BridgeBio Pharma, Inc. (BBIO)
64.82
+0.29
(+0.45%)
USD |
NASDAQ |
Mar 04, 09:55
BridgeBio Pharma Research and Development Expense (Annual) : 451.95M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Insmed, Inc. | 771.09M |
| Mirum Pharmaceuticals, Inc. | 185.83M |
| Alphatec Holdings, Inc. | 76.27M |
| Supernus Pharmaceuticals, Inc. | 106.24M |
| Cogent Biosciences, Inc. | 265.16M |